• $30.1M
    Market Cap
  • 72.09%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
03/31/2026
03/31/2025
03/31/2024
01/31/2024
Income Statement
Total Operating Revenue
32.6M
+8.29%
30.1M
N/A
N/A
N/A
28.3M
-21.71%
Cost of Revenue
19.0M
+8.26%
17.6M
N/A
N/A
N/A
17.1M
-10.06%
Gross Profit
13.6M
+8.33%
12.6M
N/A
0
-100.00%
11.1M
-40.22%
Sales and Marketing Expense
11.3M
+0.44%
11.3M
N/A
N/A
N/A
9.7M
+5,713.19%
Research and Development Expense
-12,430
-34.82%
-19,071
N/A
N/A
N/A
-16,523
-38.30%
Depreciation and Amortization Expense
1.8M
+4.35%
1.7M
N/A
N/A
N/A
1.4M
-58.26%
Total Operating Expenses
11.3M
+0.44%
11.3M
N/A
N/A
N/A
9.7M
+38.81%
Operating Profit
2.3M
+77.76%
1.3M
N/A
N/A
N/A
1.5M
-80.43%
Interest Income
65,188
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-187,241
-36.24%
-293,675
N/A
N/A
N/A
-35,210
-99.15%
Interest Income and Expense and Net
-122,053
-58.44%
-293,675
N/A
0
+100.00%
-35,210
-99.15%
Total Nonoperating Income and Expense
187,241
-36.24%
293,675
N/A
N/A
N/A
35,210
-99.15%
Income before Taxes
1.4M
+249.13%
394,921
N/A
N/A
N/A
258,657
+104.24%
Income Taxes
4.6M
+11.15%
4.2M
N/A
N/A
N/A
3.5M
+47.17%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-3.2M
-18.28%
-4.0M
N/A
N/A
N/A
-3.3M
-45.87%
Net Income from Continuing Operations Applicable to Common
-3.2M
-13.87%
-3.8M
N/A
N/A
N/A
-3.2M
-47.21%
Basic EPS and Net Income
-0.03
0.00%
-0.03
N/A
N/A
N/A
-0.03
-133.33%
Diluted EPS and Net Income
-0.03
0.00%
-0.03
N/A
N/A
N/A
-0.03
-50.00%
Basic Weighted Average Shares
117.9M
-1.57%
119.8M
N/A
N/A
N/A
120.0M
+14.50%
Diluted Weighted Average Shares
118.5M
-1.76%
120.6M
N/A
N/A
N/A
122.9M
+17.21%
Balance Sheet
Cash and Cash Equivalents
2.2M
-14.90%
2.6M
-19.48%
3.3M
+35.38%
2.4M
-61.38%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
2.2M
-14.90%
2.6M
-19.48%
3.3M
+35.38%
2.4M
-61.38%
Total Current Assets
8.3M
+10.70%
7.5M
-7.79%
8.1M
+12.37%
7.2M
-53.52%
Accumulated Depreciation
2.8M
+27.15%
2.2M
+13.13%
2.0M
+5.03%
1.9M
+80.52%
Property and Plant and Equipment and Net
2.3M
-13.74%
2.7M
-21.39%
3.4M
-1.23%
3.4M
-12.35%
Total Long-Term Assets
2.3M
-13.74%
2.7M
-21.39%
3.4M
-1.23%
3.4M
+25,208.47%
Total Assets
54.4M
-4.53%
57.0M
+3.21%
55.2M
+1.28%
54.5M
-20.75%
Income Taxes Payable
1.7M
-41.61%
2.8M
-72.30%
10.2M
+5.25%
9.7M
+165.70%
Total Short-Term Debt
732,638
-65.67%
2.1M
+84.57%
1.2M
0.00%
1.2M
+1,326.71%
Total Current Liabilities
6.4M
-19.73%
8.0M
-47.12%
15.0M
+6.23%
14.2M
-9.92%
Total Long-Term Debt
0
-100.00%
710,367
N/A
0
N/A
0
-100.00%
Total Long-Term Liabilities
100,000
-98.98%
9.8M
+6.45%
9.2M
-1.03%
9.3M
-22.41%
Total Liabilities
29.0M
+2.34%
28.3M
+16.79%
24.3M
+3.28%
23.5M
-45.98%
Retained Earnings
-80.1M
+4.22%
-76.8M
+5.45%
-72.9M
+0.10%
-72.8M
-5.01%
Total Stockholders Equity
25.4M
-11.31%
28.7M
-7.42%
31.0M
-0.24%
31.0M
+22.53%
Total Shares Outstanding
117.8M
-0.14%
118.0M
-1.71%
120.0M
0.00%
120.0M
+2.55%
Cash Flow
Cash from Operating Activities
1.4M
+13.95%
1.2M
N/A
N/A
N/A
3.3M
-66.45%
Capital Expenditures
244,838
-39.80%
406,733
N/A
N/A
N/A
521,579
-79.64%
Cash from Investing Activities
-219,838
-92.96%
-3.1M
N/A
N/A
N/A
-121,579
-88.99%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
-1.5M
-221.72%
1.3M
N/A
N/A
N/A
-2.7M
-52.61%
Financials Ratio
Gross Margin
41.71%
+0.04%
41.70%
N/A
N/A
N/A
39.42%
-16.60%
Operating Margin
6.99%
+64.15%
4.26%
N/A
N/A
N/A
5.20%
-75.01%
Return on Assets
-5.82%
-17.69%
-7.07%
N/A
N/A
N/A
-5.36%
-39.60%
Return on Equity
-11.99%
-9.92%
-13.31%
N/A
N/A
N/A
-11.72%
-51.35%
Revenue Growth
8.29%
N/A
N/A
N/A
N/A
N/A
-21.71%
N/A
Current Ratio
1.30
+37.91%
0.94
+74.36%
0.54
+5.79%
0.51
-48.40%
Cash Ratio
0.35
+6.00%
0.33
+52.28%
0.22
+27.47%
0.17
-57.14%
Debt-to-Equity Ratio
0.03
-70.97%
0.10
+165.95%
0.04
+0.27%
0.04
-55.29%
Debt-to-Assets Ratio
0.01
-72.95%
0.05
+138.76%
0.02
-1.42%
0.02
-30.72%

Earnings & Revenue History

Debt-to-Assets

Cash Flow